A detailed history of Pom Investment Strategies, LLC transactions in Exact Sciences Corp stock. As of the latest transaction made, Pom Investment Strategies, LLC holds 100 shares of EXAS stock, worth $4,519. This represents 0.01% of its overall portfolio holdings.

Number of Shares
100
Holding current value
$4,519
% of portfolio
0.01%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

BUY
$56.27 - $73.77 $5,627 - $7,377
100 New
100 $6.91 Million

Others Institutions Holding EXAS

About EXACT SCIENCES CORP


  • Ticker EXAS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 176,960,000
  • Market Cap $8B
  • Description
  • Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...
More about EXAS
Track This Portfolio

Track Pom Investment Strategies, LLC Portfolio

Follow Pom Investment Strategies, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pom Investment Strategies, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Pom Investment Strategies, LLC with notifications on news.